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Abstract
The hydroxyapatite [HAp, Ca10(PO4)6(OH)2] has a variety of applications in 
bone fillers and replacements due to its excellent bioactivity and osteoconductiv-
ity. It comprises the main inorganic component of hard tissues. Among the various 
approaches, a composite approach using several components like biopolymer, gelatin, 
collagen, and chitosan in the functionalization of scaffolds with HAp has the prospec-
tive to be an engineered biomaterial for bone tissue engineering. HAp composite scaf-
folds have been developed to obtain a material with different functionalities such as 
surface reactivity, bioactivity, mechanical strength, and capability of drug or growth 
factor delivery. Several techniques and processes for the synthesis and fabrication of 
biocompatible HAp composite scaffolds suitable for bone regeneration are addressed 
here. Further, this chapter described the excellences of various HAp composite scaf-
folds used in in vitro and in vivo experiments in bone tissue engineering.
Keywords: hydroxyapatite, scaffolds, tissue engineering, bioceramics, composite, 
stem cell
1. Introduction
Recently, regenerated bone grafts have drawn attention as a promising new bone 
grafting technology for use in tissue engineering [1]. Bone tissue engineering offers 
an alternative approach for repairing bone defects caused by trauma, malignancies, 
and congenital diseases [2]. Scaffolds are one of the key factors for bone tissue engi-
neering. The scaffolds act as substrates by providing a temporary home for growth 
and proliferation of cells. The scaffolds also provide structural and mechanical 
support for cell growth. Therefore, scaffolds should possess sufficient mechanical 
strength to provide structural support and a porous structure to guide new bone tis-
sue in-growth [1, 3, 4]. Hydroxyapatite (HAp) has been used in regenerative science 
dates back to the 1950s as an inert scaffold for filling of the bone defects [5]. It is a 
calcium phosphate bioceramic [Ca10(PO4)6(OH)2] that has widely been applied as 
scaffolds in bone tissue engineering because of high osteoconductivity and biocom-
patibility. It is a well-known bioceramic found as a major component of bone and 
tooth [6, 7]. HAp is one of the popular bioceramics used in bone tissue engineering 
because it possesses chemical structure very similar to carbonate apatite which is 
the major inorganic component of bone [8, 9]. HAp bioceramics have been widely 
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used as artificial bone substitutes because of their favorable biological properties, 
which include biocompatibility, bioaffinity, bioactivity, and osteoconduction [10]. 
HAp bioceramics contain only calcium and phosphate ions, and therefore, no 
adverse local or systemic toxicity has been reported in any study.
In tissue engineering, the interactions between tissue and HAp are impor-
tant. Therefore, it is necessary to understand the in vivo host responses for HAp. 
Generally, the mechanism of action of a biomaterial is considered to be biocompat-
ible, bioinert, biotolerant, and bioactive and includes bioresorbable materials. 
Bioactive materials form a chemical bond. The roughness and biomaterial porosity 
is considered to be an important factor for bonding. In this connection, HAp has 
displayed an ability to bond directly with the bone. It also exhibits the property of 
osteoinductivity [10, 11]. HAp scaffolds are very much recognized because of their 
osteoconduction and osteoinduction properties. Due to the provocation of the host 
mesenchymal stem cells, osteoinduction takes place in bone graft implantation. 
Therefore, these stem cells are then distinguished into bone-developing osteo-
blasts. Wide-ranging researches from worldwide have been accompanied several 
researches to recognize the osteoinduction potential of HAp over the past numerous 
years. As a result, through a number of independent studies in several hosts such 
as dogs, goats, and baboons osteoinduction has been finally detected [11–14]. In 
relation to the previous development, recently, comprehensive studies have been 
performed to construct biomimetic scaffolds materials for bone tissue engineer-
ing utilizations. Three-dimensional structure of these biomaterials is very much 
necessary for proper functioning. Few excellent properties of these scaffolds such 
as a high volume of open and interconnected pores, a bioresorbable scaffold with 
controlled resorption, appropriate mechanical properties, biocompatibility, and 
bioactivity are highly recommended in bone tissue engineering [15].
Various permeable scaffolds can be assembled by using both bioactive ceramics and 
biocompatible polymers for the application in bone tissue engineering [1]. The bioac-
tivity of graft substitutes is mostly governed by the degree of porosity of the fabricated 
biomaterials, which controls the rate of bone regeneration, local environment, and 
equilibrium of new bone at the repair site. Therefore, the osteoconductivity of the 
inductivity potential of the bone graft is synergistically promoted by the pore intercon-
nectivity, geometry, topography, and porosity modulate osteogenesis of the fabricated 
scaffolds [16–18]. Bioactive ceramics have a chemical composition resembling that of 
natural bone, allowing osteogenesis and providing bony contact and bonds with host 
bone [6, 19]. HAp is a typical bioceramic clinically used as a bone substitute, and it has 
also been used as scaffold materials in bone tissue engineering owing to its bioactivity, 
biocompatibility, and osteoconductivity. However, the low strength and toughness of 
HAp has limited its wide application in orthopedic implants [20]. The main reason for 
these low mechanical properties is thought to be the decomposition of HAp into differ-
ent calcium phosphate phases, such as tricalcium phosphate (TCP) and even tetra-
calcium phosphate (TTCP) [21]. Therefore, the mechanical properties of the HAp 
porous scaffold must be enhanced to use effectively in load-bearing compartments and 
tissue engineering applications. Various kinds of natural polymers, synthetic polymers 
(chitosan), protein (collagen), and bioceramics have been used along with HAp to 
develop composite porous scaffolds for bone tissue engineering in recent years.
2. Synthesis and fabrication processes
Scaffold fabricated by various methods acts as a substrate to stimulate cell 
adhesion, maintenance of differentiated cell function without hampering prolif-
eration. It is also a template to establish and direct the growth of cells and help in 
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the construction of extracellular matrix (ECM) [22]. Therefore, a biodegradable 
scaffold serves as a temporary skeleton in bone tissue engineering. Generally, 
when such scaffolds are inserted into the sites of faulty or lost bone to support and 
stimulate bone tissue regeneration, they gradually degrades and is replaced by new 
bone tissue [23–25]. The use of HAp as a scaffold material has been introduced in 
bone tissue engineering mainly due to its unique properties and similarity with bone 
components. The low strength and toughness of HAp has limited its wide applica-
tion in bone tissue engineering. Therefore, improved mechanical properties of the 
HAp porous scaffolds are required for the extensive range of applications and effec-
tive utilization in load-bearing compartments [1]. To overcome the brittleness of 
HAp porous body, biodegradable synthetic polymers such as poly (lactic co-glycolic 
acid) (PLGA), para-Methoxy-N-methylamphetamine (PMMA), poly(L-lactic acid) 
PLLA, and poly(ε-caprolactone) PCL are used as composites [26–29]. Even some 
attempts have been made to introduce bioceramics into polymer-based scaffolds or 
to combine synthetic polymers with natural polymers to enhance their biological 
capacity [30]. Recently, several studies are focusing on the development of HAp-
COL and HAp-COL/HAp composite scaffolds or HA-CNT nanocomposites with 
improved mechanical properties [31, 32]. HAp-COL and HAp-COL/HAp composite 
scaffolds or HA-CNT nanocomposites for orthopedic implants are synthesizing 
through template method, plasma spraying, laser surface alloying, electrophoretic 
deposition, and aerosol deposition [31, 33–37]. In addition to conventional sintering 
and hot isostatic pressing, spark plasma sintering (SPS) has also been employed to 
fabricate freestanding HA-CNT composites [38–41]. HAp-COL and HAp-COL/HAp 
composite scaffolds are also fabricated in a specific freeze-drying procedure [31].
2.1 Synthesis of HAp porous scaffolds by the template method
A template method (using polyurethane foam [PU]) was applied to prepare 
HAp porous scaffolds from HAp slurry. The HAp slurry was synthesized from 
HAp nanopowder and a 5 wt% solution of polyvinyl alcohol (PVA) (Wako Pure 
Chemical Industries, Ltd.). The HAp slurry was prepared by mixing the HAp 
powder and PVA solution at a mixing ratio of 1:1 (1 g of HAp to 1 ml of PVA) using 
a centrifuge mixing machine (Imoto Co, Ltd.). The machine was kneading for 
10 minutes and degassing (removal of gas bubbles) for 8 minutes to obtain the best 
outcome. A PU sponge sheet (HR-30, Bridgestone) was cut into cubic templates 
with dimensions of 10 × 10 × 10 mm. These cubes were then immersed into the 
ready HAp slurry. To escape blockage of the pores by the slurry, the additional 
slurry was removed by pressing the cubes at compression ratios of 50, 75, and 95%. 
To eliminate water content and to attach the HAp powders to the surface of the 
sponge framework, the cubes were then dried out at room temperature for 24 hours. 
The dried cubes were then calcined at 400°C for 6 hours and further sintered at 
1000, 1100, or 1200°C for 3 hours. The heating rate was set to 10°C/minute. The 
solidified samples were termed “pure HAp scaffolds” thereafter. The sintering 
process is illustrated schematically in Figure 1(a) [1].
2.2 Fabrication of HAp porous scaffolds with collagen and HAp particles
In a collagen-1 solution prepared, pure HAp scaffolds were dipped (Nippon Meat 
Packers Inc., Osaka, Japan) and then it was vacuumed for at least 30 minutes to 
eliminate the excess air. To synthesize HAp scaffolds with collagen coating, firstly, the 
surplus collagen solution was removed manually by pipette, and then the samples were 
dried at room temperature for at least 48 hours. On the other hand, a milk-like slime 
of HAp particles was formulated by mixing it accurately with the collagen-1 solution 
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(1:9) at 30°C and stirred continuously by a magnetic stirrer. To fabricate HAp scaffolds 
with collagen-HAp coating, the prepared slime was then poured over the pure HAp 
scaffolds. After that, the additional slime was removed and the scaffolds were dried 
out for at least 48 hours to get fabricate HAp scaffolds. The two distinct types of fabri-
cated composite scaffolds were thereafter termed as “HAp-COL” and “HAp-COL/HAp 
particle-coated scaffolds,” respectively. The detail fabrication processes of the HAp-
COL and HAp-COL/HAp scaffolds are illustrated schematically here in Figure 1(b) 
[1]. Further, a specific freeze-drying procedure was applied to fabricate coated HAp 
scaffolds form both types. The pure HAp porous composite scaffolds were frozen at 
−20°C for 24 hours and then freeze-dried at −50°C for 24 hours. These samples were 
termed “HAp-Collagen or HAp-Collagen/HAp particles two-phase scaffolds” [31].
2.3 Fabrication of HAp composite by Nd-YAG laser
HAp composite scaffolds were fabricated by a unique process where HAp pow-
ders were coated on titanium substrates at low temperature, and this coating/sub-
strate interfacing was enhanced by a laser surface engineering. In this technology, 
Nd-YAG laser was transmitted to HAp powders and the laser power was absorbed 
by titanium substrate to produce a thin layer of the molten region. Finally, in this 
procedure, HAp powders were kept at low temperature before they were entrapped 
in the metallic layer during coating [35].
Figure 1. 
Schematic of the (a) sintering processes and (b) synthesis to the fabrication of HAp porous composite scaffolds [1].
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2.4 Fabrication of HAp composite by electrophoretic deposition (EPD)
Usually, various bioactive ceramics like HAp are coated containing carbon 
nanotubes on metallic substrates through electrophoretic deposition. The EPD 
technique is described by Sing et al.. Using EPD, a variety of potentially bioactive 
ceramic coatings constructed on combinations of either HAp or titanium oxide 
nanoparticles with carbon nanotubes (CNTs) have been deposited on metallic sub-
strates. Further, sol-gel-derived ultrafine HAp powders (10–70 nm) were dispersed 
in multi-wall nanotube-containing ethanol suspensions maintained at pH = ∼3.5 
and successfully coated onto Ti alloy wires at 20 V for 1–3 minutes. Commercially 
available TiO2 nanopowders and surface-treated CNTs in aqueous suspensions were 
co-deposited on stainless steel planar substrates for TiO2/CNT coatings. A field 
strength of 20 V/cm and a deposition time of 4 minutes were used in this process to 
work at pH = 5 [36].
2.5 Fabrication of HAp composite by aerosol deposition
Hahn et al. developed an aerosol deposition technique to fabricate HAp-carbon 
nanotube (CNT) composite coatings on Ti plate. Through this aerosol deposition 
technique, authors fabricating HAp-CNT powders composites for biomedical 
applications. For the deposition process, HAp-CNT powder mixtures with CNT 
contents of 1 and 3 wt.% were used. Dense coatings with a thickness of 5 μm were 
fabricated, irrespective of the content of CNTs. The propagation and alkaline 
phosphatase (ALP) activity of MC3T3-E1 pre-osteoblast cells grown on the HAp-
CNT composite coatings was estimated. A higher propagation and alkaline phos-
phatase (ALP) activity of MC3T3-E1 pre-osteoblast cells grown on the fabricated 
HAp-CNT composite coatings was detected than those on the bare Ti and pure 
HAp coating. It was also found that by increasing the CNT content of the compos-
ite materials, an enhanced ALP activity of the composite coatings was obtained. 
Therefore, the findings suggested that for the improvement both the mechani-
cal and biological performances of HAp coatings, CNTs would be an effective 
 fortifying agent [37].
2.6 Fabrication of HAp composite by in situ chemical vapor deposition
Li et al. described a novel process to fabricate carbon nanotubes (CNTs) (Fe)/
HAp composite. By this novel process (CNTs), (Fe)/HAp composite was success-
fully prepared where CNTs homogeneously dispersed. In this procedure, at first 
Fe2O3/HAp precursor was produced and then calcined in an atmosphere of N2 gas. 
The reduction reaction was done in the presence of hydrogen of the Fe2O3/HAp 
precursor to yield Fe/HAp catalyst, and finally, in situ synthesis of nanotubes by 
chemical vapor deposition over Fe/HAp catalyst was performed. To yield CNTs 
(Fe)/HAp bulk composites, these outstanding CNTs (Fe)/HAp composite powder 
was utilized. These CNTs (Fe)/HAp bulk composites further pressed and sintered 
to produce CNTs (Fe)/HAp nanocomposites. It was analyzed that the CNTs distrib-
uted homogenously and bonded strongly with the HAp matrix [39].
2.7  Fabrication of HAp composite by poly(ε-caprolactone) (PCL) and  
poly(L-lactide) (PLLA)
PCL pallets with the molecular formula (CH2)5CO2, molecular weight (Mw) 
of 105g.mol−1, glass transition temperature Tg = −62.62°C, and melting point 
Tm = 65.4°C (Celgreen PH7, Daicel Chemistry Industries Co., Ltd.) were dissolved 
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in 1,4 dioxane (Kishida Chemical Co., Ltd., Osaka, Japan) to get the solution with a 
concentration of 1, 3, 5, 7 and 10 wt% by stirring at 60°C for 2 hours. HAp porous 
scaffolds were dipped into the solution, and it was then vacuumed for 1 hour to 
eliminate the air. For drying of these scaffolds, two different conditions were 
applied. The drenched HAp porous scaffolds were taken out from the PCL solution 
and then dried in an air oven at room temperature for 24 hours in the first drying 
process. These specimens were named as “HAp/PCL-coated scaffolds.” On the other 
hand, in the second drying process, the freeze-drying procedure was employed to 
obtain a two-phase porous construction. After excess PCL solution was removed 
from the soaked HAp porous materials, the samples were frozen at −20°C for 
24 hours and then freeze-dried at −50°C for 24 hours. These specimens were named 
as “HAp/PCL 2-phase scaffolds.” The summary of the reinforcement process is 
shown in Figure 2 [42].
3. Excellences in bone tissue engineering
The scaffolds act as a temporary substitute in bone tissue engineering and the 
interest of researchers in it as it permits mechanical support until the tissue has 
regenerated and remodeled itself naturally. It is well established that biopolymers 
such as collagen [43], chitosan [44], and hyaluronic acid [45]; biodegradable 
synthetic polymers such as poly(L-lactic acid) [46], poly(ε-caprolactone) [47], and 
polyglycolic acid (PGA) [48]; and bioactive ceramics such as hydroxyapatite [49], 
α-tricalcium phosphates [50], and β-tricalcium phosphates (β-TCP) [51] are used as 
the raw materials for the preparation of the scaffolds suitable for tissue engineering. 
These materials have been independently used to develop scaffolds, but composite 
materials have also been considered as ideal materials having mechanical stability, 
biocompatibility, cell proliferation, and easy proccessability [52–55]. However, HAp 
grows interested in scientists and researchers due to its mechanical and biological 
response and its efficiency in repairing a hard tissue defect in the composite state. 
This section will summarize the excellence of different HAp composite scaffolds for 
bone substitutes and hard tissue repair.
Figure 2. 
Schematic of biopolymer-reinforced HAp porous materials.
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3.1 In vitro experiments using HAp composite scaffolds
Phanny (in our lab) conducted a study using HAp/PCL-coated scaffold and 
HAp/PCL two-phase scaffold to investigate the mechanical properties variation, 
biocompatibility, and differentiation efficiency within 4 weeks of cell culture in a 
standard medium and osteoblast differentiation medium [42]. Human mesenchy-
mal stem cells (hMSCs) were seeded in both types of scaffold for 1–4 weeks with an 
α-minimum essential medium eagle with L-glutamine and phenol red (MEMα) for 
the growth and with osteoblast differentiation medium for cellular differentiation. 
The author reported that both HAp/PCL-coated scaffold (Figure 3, left) and HAp/
PCL two-phase scaffolds were biocompatible where hMSCs have grown and prolif-
erated rapidly (Figure 3, right). The level of p-nitrophenol obtained via ALP assay 
of both types of scaffolds are almost the same because the cells tended to proliferate 
in standard medium rather than differentiation. The cells cultured in osteoblast 
differentiation medium were able to differentiate into an osteoblastic lineage with 
an increasing level of p-nitrophenol and density of ARS staining. It was also found 
that specimens without cell seeding continuously decreased in both elastic modulus 
and compressive strength in both standard medium and osteoblast differentiation 
medium and remained lower than that of specimens with cell culture.
Therefore, it was concluded that the ability to allow cells to grow, proliferate, dif-
ferentiate, and maintain mechanical properties of HAp/PCL-coated and two-phase 
scaffolds are a high potential candidate for bone tissue engineering applications [42].
Figure 3. 
FE-SEM images of the morphology of cell growth on HAp/PCL-coated (left) and HAp/PCL two-phase 
scaffolds (right).
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It was reported in our previous study that hMSCs could be successfully cultured 
over HAp-COL and HAp-COL/HAp scaffolds. It was confirmed from that evalua-
tion that the scaffolds exhibited the best performance in terms of mechanical prop-
erties at a 50% compressive ratio. Figure 4 represents the FE-SEM micrographs of 
the surface regions of composite scaffolds with hMSCs [1]. In this figure, hMSCs’s 
adhesion and proliferation behaviors up to 7 days of culturing were observed on 
the surfaces. The FE-SEM micrographs of hMSCs cultivated over the fabricated 
composite scaffolds of HAp-COL and HAp-COL/HAp sintered at 1000, 1100, and 
1200°C are shown in figures (a), (c), and (e), and (b), (d), and (f), respectively. 
Most cells adhered tightly to the surface and were well disseminated. These results 
indicated that the composite scaffolds had favorable bioactivity for the promotion 
of cell adhesion and proliferation far excelling than that of pure HAp scaffolds. The 
effects of the compressive ratio and sintering temperature on cell-scaffold interac-
tions were evaluated through a cell proliferation assay using a cell-counting kit up to 
14 days of culture.
The growth performance of hMSCs over the constructed porous composite 
scaffolds is exhibited in Figure 5. Primarily, 1 × 104 cells were seeded on the fabri-
cated porous composite scaffolds. After the cells seeding well, the cell proliferation 
Figure 4. 
The FE-SEM images of 7 days culture period of hMSCs over HAp-COL and HAp-COL/HAp porous composite 
scaffolds fabricated at a 50% compressive ratio and sintered at (A) 1000C, (B) 1100°C, and (C) 1200°C. the 
FE-SEM images HAp-COL and HAp-COL/HAp porous composite scaffolds are represented by (a), (c), and 
(e) and (b), (d), and (f) at sintering temperature 1000°C, 1100°C, and 1200°C, respectively [1].
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behavior was recorded at 7 and 14 days of culture. It was noteworthy that the cell 
number increased until 7 days of culture for all types of scaffolds, while cell mul-
tiplication declined as the culturing days continued. The growth performance of 
hMSCs over the HAp-COL scaffolds sintered at 1000, 1100, and 1200°C displayed 
distinctive trend over their counterparts [1].
Wahl and Czernuszka summarized and compared a few excellent reports of in vitro 
experiments using HAp composite scaffolds and are listed here in Table 1 [56].
3.2 In vivo experiments using HAp composite scaffolds
Cai et al. fabricated coral hydroxyapatite (CHAp) as a cuboid of 
5 mm × 5 mm × 10 mm with an inclined groove. In this study, the prepared CHAp 
biomaterials was highly porous (porosity: 30–70%) with a fully interconnected 
pore with an average pore diameter of 100–600 μm. Here, the induced BMSCs 
Figure 5. 
The proliferation of hMSCs in HAp-COL and HAp-COL/HAp composite scaffolds fabricated at a 50% 
compressive ratio and sintered at 1000, 1100, and 1200°C with up to 14 days of culture. Each set of data 
represents the mean ± SD, n = 6, *p < 0.05 [1].
Composites Cell culturing or implantation Period (new tissue formed)
HA-Collagen(Du et al.) [57] Bone extract wrapped around 
composite osteogenic cells
21 days (mineralized bone)
HA-Collagen(Clarke et al.) [58] Human-derived bone cell culture 32 days (connective tissue and 
mineralized bone)
HA-Collagen(Wu et al.) [59] Osteoblasts from rat calvaria 21 days (mineralized bone)
HA-Collagen(Wang et al.) [60] Chondrocytes in a closed chamber 49 days (cartilage)
HA-Collagen-Elastin(Rovira 
et al.) [61]
Osteoblasts from trabecular bone 15 days (mineralized bone)
Table 1. 
In vitro experiments in bone tissue engineering using different HAp composites.
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were seeded on sterilized CHAp scaffold by a concentration of 20 × 106 cells/ml 
(200 ± 17 μL/scaffold, about 4 × 106 cells/scaffold) and were 3D cultured for 1 week 
before implantation. The growth behavior of BMSCs on the CHAp scaffold was 
assessed by using a scanning electron microscope and confocal laser electronic 
microscope [62]. The authors described an effective methodology to generate bone 
tissue and healing bone defect in ectopic and orthotopic sites. In this methodology, 
a tissue-engineered bone flap with a vascular pedicle of saphenous arteriovenous 
with an organized vascular network was observed after 4 weeks of implantation 
and followed by a successful repair of the fibular defect in beagle dogs (Figure 6).
Engineered bone formation in ectopic and orthotopic sites after implantation 
of 9 months over four CHAp scaffold groups were evaluated by CT (computed 
tomography) analysis. The stimuluses of vascularization and micro-environment 
on tissue-engineered bone were quantitatively analyzed by the comparison of bone 
formation and scaffold degradation between different groups (Figure 7). The 
results indicated that in the first 3 months, vascularization improved engineered 
bone formation by 2 times of non-vascular group and bone defect micro-environ-
ment improved it by 3 times the ectopic group, and the CHAp scaffold degradation 
was enhanced as well [62]. In the VSC group, the HE staining of decalcified paraf-
fin sections after 3 months embedding exhibited that there was a minor volume 
of bone-like tissue developed at the surface of the CHAp scaffold (Figure 7(B)). 
Figure 7(C) and (D) indicates the gradual improvement of engineered bone tissue 
after 6 months and a well-developed Haversian system with little residual scaffold 
remaining after 9 months, respectively. In the SC group, after 3 months of implan-
tation, only the osteoid was shown and until 6 months of implantation, there was 
no significant bone formation, but after 9 months of implantation, engineered bone 
tissue enlarged with much residual scaffold (Figure 7(E)–(H)). Figure 7(I)–(P) 
denotes the gradual degradation of the CHAp scaffolds without bone formation in 
both VS and S groups, the pores of the majority of CHAp scaffold fill with fibrous 
connective tissue and a large number of inflammatory cells. Moreover, more typical 
vascular structures and less inflammatory cells were seen in the VS group than that 
in the S group (Figure 7L and P).
In another study, Kikuchi et al. (2001) fabricated a biodegradable hydroxyapa-
tite/collagen (HAp/Col) nanocomposite [63]. In this method, through the lyophili-
zation of the precipitate of HAp/Col composites, HAp/Col powder was formulated. 
About 0.5 g of the prepared HAp/Col powder was well mixed with 3 ml of 0.9% 
NaCl solution (Wako, Japan) and 35 Al of 5 M CaCO3 (Wako). In a 0.9% NaCl 
Figure 6. 
Representation of the vascularization over MSC coral hydroxyapatite scaffold using cell-CHA constructs at 
4 weeks post-implantation. Here, (A) and (B) represent CT angiography and (C) and (D) indicate ultrasonic 
inspection. Further, (E) and (F) indicate X-ray before and after vascular corrosion cast and (G) represent 
vascular corrosion cast. HE and Masson’s trichrome staining of cell-CHA constructs in undecalcification 
sections and decalcification sections is indicated by (H), (I), and (J), respectively. Scale bars: 10 mm (F), (G), 
50 mm (H)–(J) [62].
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solution, 1.5 ml of 3% sodium alginate (Wako) was added, dissolved, and mixed. 
D-gluconic acid lactone (60 mg, Sigma, USA) was added to the HAp/Col-alginate 
mixture to initiate gelation, and the mixture was injected into a mold and left for 
45 minutes at room temperature. The composite has a bone-like nanostructure; the 
length of the HAp crystals is up to 50 nm. The authors investigated the capability 
of HAp/Col-alginate as a bone filler in the rat femur and as a carrier of BMP using 
an ectopic bone formation model (Figure 8). Vigorous bone growth around the 
fabricated scaffolds and tissue invasion into these scaffolds was observed during the 
experiment. A comparison was made between those observed for simple alginate 
and porous HAp. Furthermore, HAp/Col-alginate was investigated as a carrier of 
recombinant human bone morphogenetic protein 2 (rh-BMP2). It was revealed that 
bone formation throughout the implant 5 weeks after implantation without obvious 
deformation of the material was obtained by using the HAp/Col-alginate (20 μl) 
with the rh-BMP2 (100 μg/ml, 15 μl), whereas bone development was detected 
only in a part of a squashed collagen sponge [64]. In Figure 8 (A–C), prominent 
bone formation of the HAp/Col-alginate treated with the 100 μg/ml BMP solu-
tion was remarkably extended throughout almost the whole implant, and bone 
marrow-like tissue also developed. It was noticed that the implants shrank when 
there was no bone formation. Further, it was observed that ectopic bone formation 
was obtained using collagen sponge treated with the 100 μg/ml of rh-BMP2 solu-
tion, but new bone had not extended all through the implant even after 5 weeks 
(Figure 8(D)) [64].
Figure 7. 
Histological observation of different CHAp-scaffold constructs implanted into spatium intramuscular of the 
hind limb at 1, 3, 6, and 9 months post-implantation (HE staining; S, CHA scaffold; TB, tissue-engineered 
bone). Scale bars: 50 mm. Here, HE staining of decalcified paraffin sections is showed. In VSC group, bone-like 
tissue formation at the surface of the CHA scaffold after 1 and 3 months implantation are indicated by plate 
(A) and (B), respectively; gradual increase of engineered bone tissue after 6 months and visible well-developed 
Haversian system after 9 months implantation are indicated by plate (C) and (D), respectively. In SC group, 
visible osteoid after 3 months, no significant bone formation until 6 months and engineered bone tissue 
increased with much residual scaffold remaining after 9 months implantation are represented by (E), (F), (G), 
and (H), respectively. Filling the pores of the CHA scaffolds in both VS and S groups with fibrous connective 
tissue and a large number of inflammatory cells indicated by (I–P).
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Ripamonti et al. conducted spontaneous induction research of bone forma-
tion in heterotopic rectus abdominis and orthotopic calvarial sites by coral-derived 
biomimetic matrices of different chemical compositions. The authors conducted a 
long-term study in the non-human primate Papio ursinus. In this methodology, rods 
(diameter 20 mm × and 7 mm) were implanted in heterotopic rectus abdominis sites; 
discs (diameter 25 mm) were implanted in orthotopic calvarial defects of six adult 
non-human primates, P. ursinus. Fully converted hydroxyapatite replicas sintered 
at 1100°C were used as heterotopic samples. These fully converted hydroxyapatite 
replicas were coated with the synthetic peptide P15 known to increase the adhesion 
of fibroblasts to an organic bovine mineral to further enhance the spontaneous 
osteoinductive activity. Thereafter, bone induction was evaluated by a histologi-
cal examination, alkaline phosphatase, and osteocalcin expression, as well as by 
the expression of BMP-7, GDF-10, and collagen type IV mRNAs at 60, 90, and 
365 days. Bone induction occurred in the concavities of the scaffolds matrices at 
all time points. It was evident of bone marrow formation in the P15-coated and 
uncoated implants at 365 days. Moreover, resorption of partially converted calcium 
carbonate/hydroxyapatite and remodeling of the newly formed bone was apparent. 
The northern blot analyses of samples from heterotopic specimens indicated high 
levels of expression of BMP-7 and collagen type IV mRNA in all samples at 60 days. 
Therefore, it was correlating with the induction of the osteoblastic phenotype 
in invading fibrovascular cells. Expanded bone formation across the different 
implanted constructs of the orthotopic samples was also observed (Figure 9).
The concavities of the biomimetic matrices and the remodeling cycle of the osteo-
genic primate cortico-cancellous bone stimulate the ripple-like cascade of the induction 
of bone formation. It is demonstrated for the first time through this study that sponta-
neous differentiation of bone was induced by partially converted HAp/CC constructs. 
It was noted that this bone induction was only seen 1 year post-implantation [12].
Figure 8. 
BMP2 (100 μg/ml) induced ectopic bone formation after 5 weeks of implantation. Here, (A–C) denote HAp/
col-alginate with BMP; (A), (B), (C), and (D) stand for HE section of the whole implant, immunostaining 
section with antiosteocalcin, higher magnification, and collagen sponge with BMP, respectively. Here, bone 
marrow-like tissue was indicated by white arrows. Further, black arrowheads and white arrowheads indicate 
soft and bone, respectively [64].
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Ripamonti et al. also fabricated osteoinductive titanium implants for the induc-
tion of bone formation. The experimental titanium implants were prepared with 
a sequence of 36 repetitive concavities. The estimated diameter, depth, and space 
distance of these concavities was 1600, 800, and 1000 μm, respectively. To prepare 
edentulous mandibular ridges for later implantation, mandibular molars and pre-
molars were taken out. After a healing period of 7–8 months, in the left and right, 
edentulized hemi-mandibles planar and geometric hydroxyapatite-coated titanium 
constructs were entrenched, respectively. In this study, three planar and three 
geometric implants were implanted in the left and right tibiae, respectively; addi-
tionally, planar and geometric constructs were also inserted in the rectus abdominis 
muscle. A total of six animals were euthanized at 30 and 90 days after implantation 
for this study; one animal was euthanized 5 days after surgery, and the remaining 
animal was euthanized 31 months after implantation. Undecalcified longitudinal 
Figure 9. 
Demonstration of calvarial incorporation of 13% hydroxyapatite/calcium carbonate paradigms collected on 
60 (A, E, F), 90 (B, F, G, H), and 365 days (C, D, and I) after implantation in calvarial defects of Papio 
ursinus. Here, (a) stands for islands of newly formed bone (blue arrows) scattered within the internal and 
central regions of the implanted coral-derived construct; (E and F) stand for the induction of bone formation 
within the porous spaces of the implanted biomimetic matrices; (B, F, G, and H) stand for induction of 
bone formation in porous biomimetic constructs harvested 90 days after implantation in calvarial defects. 
Further, (C, D, and I) denote calvarial constructs harvested on day 365 after implantation showing significant 
induction of bone formation with solid blocks (I) of newly formed bone [12].
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sections were precision-sawed, ground, and polished to 40–60 μm; all sections 
were stained with a modified Goldner’s trichrome. By the EXAKT precision cutting 
and grinding system, undecalcified specimen block preparation was accomplished. 
Histomorphometric analyses of bone in contact (BIC) revealed that there was no 
difference between the geometric vs. planar control implants on day 30; on the 
other hand, on day 90, the ratio of BIC to surface within the geometric implants 
was greater than that of the standard planar implants in both mandibular and tibial 
sites. Further, selected concavities cut into the geometric implants harvested from 
the rectus abdominis muscle 31 months after implantation exhibited the spontane-
ous induction of bone formation with mineralized bone surfaced by osteoid seams 
(Figure 10). Therefore, these data in non-human primates indicate that geo-
metrically constructed plasma-sprayed titanium implants are per se osteogenic, the 
concavities providing a unique microenvironment to initiate bone differentiation by 
induction [65].
Figure 10. 
Tissue evolution, induction, remodeling, and osteointegration within the in vivo bioreactor of the concavities 
90 days after implantation within the edentulized hemi-mandibles of the non-human primate Papio ursinus. 
Here, (A) denotes the instrumental for the preparation of the geometric implants, attachment, orientation, 
and alignment of MC 3 T3-E1 cells in vitro within the geometric cue of the concavity of the coral-derived 
calcium phosphate macroporous construct. (B) Indicates insertion into the edentulous ridge of the non-human 
primate P. ursinus, the concavities of the in vivo bioreactor adsorb plasma and plasma products during the 
surgical procedure (blue arrow) but not the planar linear inter-concavity spaces. Further, osteointegration 
along the geometric implant with marrow spaces within the concavity osteointegrated space is denoted by 
(C) and (D) (blue arrow), whereas mineralized remodeled bone tightly integrated with the hydroxyapatite 
coating, remodeling, and blending into the highly crystalline hydroxyapatite layer are denoted by E, F, G, H, 
respectively (H blue arrow) [65].
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In a previous study, porous composite biomaterial of hydroxyapatite (HAp) 
and periosteal graft was used to repair an induced maxillary bone defect where a 
defect was created in the premaxillary bone of rats. In this study, four groups were 
used: (1) those treated with the mucoperiosteal graft from the premaxilla, (2) those 
treated with HAp combined with a mucoperiosteal graft from the premaxilla, (3) 
those treated with HAp combined with a periosteal graft from the femur, and (4) 
those treated with a periosteal graft from the femur. It was revealed from the radio-
graphic evaluation from all groups that no signs of bone formation after 2 weeks 
were detected but radiolucency was found inside the HAp implants after 16 weeks. 
It was clear that cell proliferation occurred from the periosteum covering the defect. 
Moreover, bone tissue formation was detected from the defect margin to inside the 
defect in all cases. Interestingly, after 8 and 16 weeks of implantation, mature bone 
was observed around the HAp implants (Figure 11). Therefore, it was concluded 
that the periosteal graft provides reasonable support to the HAp implant, allowing 
the development of new bone [66].
Figure 11. 
A histologic frontal section through bone defect covered with mucoperiosteum from the premaxilla combined 
with HA (group 2). After 16 weeks, the defect in the premaxilla was partially occupied by newly formed bone 
(white stars) with a mature appearance and by the HA blocks, while there were spaces filled by connective 
tissue. The mucoperiosteum from the premaxilla remained the HA blocks in the defect (black arrow). 
(Original magnification 32; hematoxylin-eosin stain).
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Moreover, Wahl and Czernuszka (2006) summarized and compared a few excel-
lent reports of in vivo experiments using HAp composite scaffolds and are listed 
here in Table 2 [56].
The biodegradable porous scaffolds of HAp synthesized and fabricated by the 
mentioned methods showed several advantages and disadvantages. The porosity 
of the HAp scaffolds plays an important role in tissue engineering to control cell 
functions and to guide the formation of new tissues and organs. Therefore, no 
matter what the materials are, scaffolds must have sufficient porosity to allow for 
cellular infiltration and proper cell function [31]. The fabricated pore structures 
of HAp scaffolds facilitated cell seeding, cell penetration, and distribution in 
the scaffolds. On the other hand, the bottleneck of the mentioned methods was 
time-consuming.
4. Conclusion
Recently, bone and cartilage generation by autogenous cell/tissue transplanta-
tion has become one of the most promising techniques in orthopedic surgery and 
biomedical engineering. Several scaffold materials have been investigated for tissue 
engineering bone and cartilage. Hydroxyapatite (HAp) composite is an eminent 
one among them. It has been investigated for its clinical viability in various bone 
defects since the mid-1980s. Synthetic HAp exhibits good properties as a biomate-
rial, such as biocompatibility, bioactivity, and osteoconductivity. Therefore, it has 
been widely used as a bone substitute, coating on metallic implants, and scaffold 
for tissue engineering. HAp along with other biopolymers, ceramics, and metals 
produced composite scaffolds to enhance the ease of application of tissue engineer-
ing. HAp-COL and HAp-COL/HAp composite scaffolds or HAp-CNT nanocom-
posites for orthopedic implants are synthesized and fabricated through template 
method, plasma spraying, laser surface alloying, electrophoretic deposition, aerosol 
deposition, and a specific freeze-drying procedure. Several in vitro and in vivo 
experiments conducted worldwide demonstrated and proved the inevitabilities and 
excellences of HAp composite scaffolds in bone tissue regeneration and engineering.
Composites Cell culturing or implantation Period (new tissue formed)
CO3Appatite-Collagen 
(Okazaki et al.) [67]
Implantation in rat periosteum cranii 21 days (mineralized bone)
PCCA-TCP-Collagen  
(Du et al.) [68]
Implantation in rat thigh muscle 7 days (connective tissue and 
capillary vessels)
HA-Collagen (Kikuchi et al.) 
[69]
Implantation in beagle tibia 54 days (mineralized bone)
HA-Collagen (Itoh et al.) [70] Implantation in beagle cervical spine 14 days (start of callus formation)
FGMgCO3Ap-Collagen 
(Yamasaki et al.) [71]
Implantation in rat periosteum cranii 14–28 days (mineralized bone)
HA-Collagen Alginate 
(Sotome et al.) [64]
Implantation in the rat femur 14 days (mineralized bone)
nHA-Anionic Collagen 
(Martins and Goissis) [72]
Implantation in rat infraorbital bone 60 days (mineralized bone)
cAP-Collagen (Suh et al.) [73] Implantation in rabbit skin 98 days (mineralized bone)
Table 2. 
In vivo experiments in bone tissue engineering using different HAp composites.
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